Publications by authors named "K Shiina"

In super-aged societies, dementia has become a critical issue, underscoring the urgent need for tools to assess cognitive status effectively in various sectors, including financial and business settings. Facial and speech features have been tried as cost-effective biomarkers of dementia including Alzheimer's disease (AD). We aimed to establish an easy, automatic, and extensive screening tool for AD using a chatbot and artificial intelligence.

View Article and Find Full Text PDF

Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, was classically attributed to alpha-synuclein aggregation and consequent loss of dopaminergic neurons in the substantia nigra pars compacta. Recently, emerging evidence suggested a broader spectrum of contributing factors, including exosome-mediated intercellular communication, which can potentially serve as biomarkers and therapeutic targets. However, there is a remarkable lack of comprehensive studies that connect the serum exosome microRNA (miRNA) transcriptome with demographic, clinical, and neuroimaging data in PD patients.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is one of the risk factors for atrial fibrillation (AF). However, the mechanism underlying the atrial structural and electro-anatomical remodeling by OSA has not yet been clearly elucidated.

Methods: This study was conducted in 83 patients who had undergone catheter ablation for AF (49 with OSA and 34 Controls without OSA).

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effects of starting sacubitril/valsartan (Sac/Val) therapy during hospitalization for acute heart failure (AHF) on NT-proBNP levels in Japanese patients.
  • It involved a randomized trial with 400 patients, comparing those who switched to Sac/Val versus those who continued standard therapy, measuring changes in NT-proBNP at 4 and 8 weeks.
  • Results showed that the Sac/Val group experienced significantly greater reductions in NT-proBNP levels, particularly in patients with lower left ventricular ejection fractions, with no significant safety concerns noted.
View Article and Find Full Text PDF

Obstructive Sleep Apnea (OSA) and hypertension have a high rate of co-occurrence, with OSA being a causative factor for hypertension. Sympathetic activity due to intermittent hypoxia and/or fragmented sleep is the most important mechanisms triggering the elevation in blood pressure in OSA. OSA-related hypertension is characterized by resistant hypertension, nocturnal hypertension, abnormal blood pressure variability, and vascular remodeling.

View Article and Find Full Text PDF